Obesity does not affect survival outcomes in extremity soft tissue sarcoma

Area of Science:

• Oncology
• Surgical Oncology
• Epidemiology

Background:

• Obesity is a growing global health concern with known links to increased surgical complications.
• Adipose tissue may create a microenvironment that supports tumor progression.
• The impact of obesity on the prognosis of soft tissue sarcomas remains largely unevaluated.

Purpose of the Study:

• To determine if obesity (Body Mass Index [BMI] ≥ 30 kg/m²) affects survival outcomes in extremity soft tissue sarcoma patients.
• To assess the influence of obesity on wound healing and other surgical complications post-treatment.
• To analyze local recurrence, distant metastasis, and disease-specific death in relation to patient BMI.

Main Methods:

• A cohort of 397 patients (154 obese, 243 non-obese) with extremity soft tissue sarcomas was analyzed.
• Data were collected from a prospective database between 2001 and 2008, with a mean follow-up of 3.9-4.5 years.
• Survival outcomes and complication rates were stratified by BMI, and multivariable models identified independent predictors.

Main Results:

• Obese patients exhibited similar survival outcomes and wound complication rates compared to non-obese patients.
• Obese patients were more likely to have lower-grade tumors and comorbidities like diabetes, hypertension, and a history of smoking.
• Regression analysis indicated that obesity was not an independent risk factor for survival outcomes, even after adjusting for tumor characteristics and comorbidities.

Conclusions:

• Despite the increasing prevalence of obesity and its associated health risks, it does not seem to negatively impact survival or wound complication rates in extremity soft tissue sarcoma patients.
• The findings suggest that obesity status should not be a primary concern when evaluating prognosis for this specific patient group.
• Further research may explore the complex interplay between obesity, tumor biology, and sarcoma progression.